Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir in HCV patients on dialysis
NCT03036839Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ledipasvir in chronic hepatitis C (CHC), sponsored by Gilead Sciences. Started Jun 2017; status: completed.
02
Drugs
ledipasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT03036839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03036839.